Case report: Parvovirus B19 encephalitis following rituximab therapy in a patient with immune-mediated thrombocytopenia.

Campolo V, Kitzrow M, Lucchese G, Sturm D

Open source

DOI
10.3389/fimmu.2026.1698621
Published
2026
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1698621,
  title = {Case report: Parvovirus B19 encephalitis following rituximab therapy in a patient with immune-mediated thrombocytopenia.},
  author = {Campolo V and Kitzrow M and Lucchese G and Sturm D},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1698621},
  url = {https://doi.org/10.3389/fimmu.2026.1698621}
}

RIS

TY  - JOUR
TI  - Case report: Parvovirus B19 encephalitis following rituximab therapy in a patient with immune-mediated thrombocytopenia.
AU  - Campolo V
AU  - Kitzrow M
AU  - Lucchese G
AU  - Sturm D
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1698621
UR  - https://doi.org/10.3389/fimmu.2026.1698621
ER  - 

APA

V, C., M, K., G, L., & D, S. (2026). Case report: Parvovirus B19 encephalitis following rituximab therapy in a patient with immune-mediated thrombocytopenia.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1698621

Source records